Inventor
Robert James Gleave
Inventor
Harlow, GB
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes30%
PatentTitleYear
9,750,719'Tetrazole compounds as calcium channel blockers'20179,115,132'Tetrazole compounds as calcium channel blockers'20158,536,183'3-pyridylcarbonyl-piperazinylsulfonyl derivatives'20138,530,478'Piperazine derivatives used as CAV2.2 calcium channel modulators'20138,288,388'3-pyridylcarbonyl-piperazinylsulfonyl derivatives'20128,048,907'Receptor antagonists and their methods of use'20117,935,832'Pyrrole and isoindole carboxamide derivatives as P2X7 modulators'20117,932,282'Imidazolidine carboxamide derivatives as P2X7 modulators'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2013Based in Harlow, GB· patent location history
2012–2017Patents assigned to CONVERGENCE PHARMACEUTICALS (5)· patent assignee history
2012–2015Patents assigned to GLEAVE ROBERT JAMES (4)· patent assignee history
2012–2015Patents assigned to VILE SADIE (4)· patent assignee history
2012–2013Patents assigned to BESWICK PAUL JOHN (3)· patent assignee history
2012–2013Patents assigned to CAMPBELL ALISTER (3)· patent assignee history
2015–2017Based in Cambridge, GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CONVERGENCE PHARMACEUTICALS | 5 | 2012–2017 |
| GLEAVE ROBERT JAMESself | 4 | 2012–2015 |
| VILE SADIE | 4 | 2012–2015 |
| BESWICK PAUL JOHN | 3 | 2012–2013 |
| CAMPBELL ALISTER | 3 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Harlow, GB | 6 | 2011–2013 |
| Cambridge, GB | 2 | 2015–2017 |